The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemes...

Tekijä Hadji, Peyman, Stoetzer, Oliver, Decker, Thomas, Kurbacher, Christian M., Marmé, Frederik, Schneeweiss, Andreas, Mundhenke, Christoph, Distelrath, Andrea, Fasching, Peter A., Lux, Michael P., Lüftner, Diana, Janni, Wolfgang, Muth, Mathias, Kreuzeder, Julia, Quiering, Claudia, Grischke, Eva-Marie, Tesch, Hans
Julkaisussa J Bone Oncol (2018)

Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor‐positive, human epidermal growth factor receptor 2‐negative locally advanced or meta...

Tekijä Tesch, Hans, Stoetzer, Oliver, Decker, Thomas, Kurbacher, Christian M., Marmé, Frederik, Schneeweiss, Andreas, Mundhenke, Christoph, Distelrath, Andrea, Fasching, Peter A., Lux, Michael P., Lüftner, Diana, Hadji, Peyman, Janni, Wolfgang, Muth, Mathias, Kreuzeder, Julia, Quiering, Claudia, Taran, Florin‐Andrei
Julkaisussa Int J Cancer (2018)

Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis

Tekijä Schnittger, Susanne, Bacher, Ulrike, Haferlach, Claudia, Beelen, Dietrich, Bojko, Peter, Bürkle, Dieter, Dengler, Robert, Distelrath, Andrea, Eckart, Michael, Eckert, Robert, Fries, Stefan, Knoblich, Jan, Köchling, Georg, Laubenstein, Hans-Peter, Petrides, Petro, Planker, Manfred, Pihusch, Rudolf, Weide, Rudolf, Kern, Wolfgang, Haferlach, Torsten
Julkaistu 2009